Viking Therapeutics
VKTX
#2413
Rank
โ‚ฌ5.81 B
Marketcap
52,17ย โ‚ฌ
Share price
-9.14%
Change (1 day)
462.24%
Change (1 year)

Earnings for Viking Therapeutics (VKTX)

Earnings in 2024 (TTM): -โ‚ฌ90.68 Million

According to Viking Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โ‚ฌ81.39 Million a decrease over its 2022 earnings that were of -โ‚ฌ65.26 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Viking Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ90.68 Million11.41%
2023 -โ‚ฌ81.39 Million24.73%
2022 -โ‚ฌ65.26 Million25.24%
2021 -โ‚ฌ52.11 Million39.23%
2020 -โ‚ฌ37.43 Million53.21%
2019 -โ‚ฌ24.43 Million16.84%
2018 -โ‚ฌ20.91 Million7.22%
2017 -โ‚ฌ19.5 Million39.68%
2016 -โ‚ฌ13.96 Million-37.05%
2015 -โ‚ฌ22.18 Million6.94%
2014 -โ‚ฌ20.74 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.5 Billion 424.51%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.56 M-103.80%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ20.32 M-121.64%๐Ÿ‡บ๐Ÿ‡ธ USA